title: Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements. Final rule.
abstract: This final rule outlines annual reporting requirements for practitioners who are authorized to treat up to 275 patients with covered medications in an office-based setting. This final rule will require practitioners to provide information on their annual caseload of patients by month, the number of patients provided behavioral health services and referred to behavioral health services, and the features of the practitioner's diversion control plan. These reporting 
  requirements will help the Department of Health and Human Services (HHS) ensure compliance with the requirements of the final rule, 
  "Medication Assisted Treatment for Opioid Use Disorders," published in the Federal Register on July 8, 2016.
mesh_terms: D002047:Buprenorphine / Q000600:supply & distribution* / Q000627:therapeutic use*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D019221:Mandatory Reporting; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D064226:Prescription Drug Diversion / Q000331:legislation & jurisprudence / Q000517:prevention & control; D014481:United States
chemical_list: D002047:Buprenorphine